Frontiers in Pharmacology (Dec 2022)

Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway

  • Ruixue Guo,
  • Ruixue Guo,
  • Peipei Wang,
  • Peipei Wang,
  • Xuejun Zheng,
  • Xuejun Zheng,
  • Wen Cui,
  • Wen Cui,
  • Jin Shang,
  • Jin Shang,
  • Jin Shang,
  • Zhanzheng Zhao,
  • Zhanzheng Zhao,
  • Zhanzheng Zhao

DOI
https://doi.org/10.3389/fphar.2022.1074294
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords